Logo image of SLHG

SKYLIGHT HEALTH GROUP INC (SLHG) Stock Fundamental Analysis

NASDAQ:SLHG - Nasdaq - CA83086L2057 - Common Stock - Currency: USD

0.5847  -0.01 (-1.75%)

After market: 0.588 +0 (+0.56%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SLHG. SLHG was compared to 102 industry peers in the Health Care Providers & Services industry. SLHG may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SLHG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SLHG had negative earnings in the past year.
SLHG Yearly Net Income VS EBIT VS OCF VS FCFSLHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -5M -10M -15M -20M

1.2 Ratios

Industry RankSector Rank
ROA -42.34%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLHG Yearly ROA, ROE, ROICSLHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -200 -400 -600

1.3 Margins

Industry RankSector Rank
OM -61.09%
PM (TTM) -48.43%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLHG Yearly Profit, Operating, Gross MarginsSLHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K -8K -10K

More info and screens

1

2. Health

2.1 Basic Checks

SLHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SLHG has been increased compared to 1 year ago.
The debt/assets ratio for SLHG is higher compared to a year ago.
SLHG Yearly Shares OutstandingSLHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
SLHG Yearly Total Debt VS Total AssetsSLHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

SLHG has an Altman-Z score of -1.43. This is a bad value and indicates that SLHG is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.07 is on the high side and indicates that SLHG has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z -1.43
ROIC/WACCN/A
WACC10.44%
SLHG Yearly LT Debt VS Equity VS FCFSLHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.21 indicates that SLHG should not have too much problems paying its short term obligations.
A Quick Ratio of 1.21 indicates that SLHG should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
SLHG Yearly Current Assets VS Current LiabilitesSLHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

SLHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
SLHG shows a strong growth in Revenue. In the last year, the Revenue has grown by 383.90%.
The Revenue has been growing by 610.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)383.9%
Revenue growth 3Y36.12%
Revenue growth 5Y610.49%
Sales Q2Q%133.78%

3.2 Future

The Earnings Per Share is expected to decrease by -10.67% on average over the next years. This is quite bad
Based on estimates for the next years, SLHG will show a very strong growth in Revenue. The Revenue will grow by 44.87% on average per year.
EPS Next Y-78.91%
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%
EPS Next 5Y-10.67%
Revenue Next Year60.93%
Revenue Next 2Y51.58%
Revenue Next 3Y47.68%
Revenue Next 5Y44.87%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SLHG Yearly Revenue VS EstimatesSLHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
SLHG Yearly EPS VS EstimatesSLHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SLHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SLHG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLHG Price Earnings VS Forward Price EarningsSLHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.81
SLHG Per share dataSLHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

SLHG's earnings are expected to decrease with -13.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SKYLIGHT HEALTH GROUP INC

NASDAQ:SLHG (8/24/2022, 8:00:02 PM)

After market: 0.588 +0 (+0.56%)

0.5847

-0.01 (-1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-15 2022-08-15/amc
Earnings (Next)11-14 2022-11-14
Inst Owners0.5%
Inst Owner Change-36.48%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.28M
Analysts77.5
Price Target2.08 (255.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB N/A
EV/EBITDA -1.81
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.21
BVpS0.5
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -61.09%
PM (TTM) -48.43%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -1.43
F-Score2
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y-78.91%
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%
EPS Next 5Y-10.67%
Revenue 1Y (TTM)383.9%
Revenue growth 3Y36.12%
Revenue growth 5Y610.49%
Sales Q2Q%133.78%
Revenue Next Year60.93%
Revenue Next 2Y51.58%
Revenue Next 3Y47.68%
Revenue Next 5Y44.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A